生殖遺傳學市場－全球產業規模、佔有率、趨勢、機會和預測（按組件、按技術、按程序類型、按應用、按地區和競爭細分，2020-2030 年預測）

2024年全球生殖遺傳學市場規模為58.7億美元，預計到2030年將達到125.6億美元，預測期內複合年成長率為13.52%。全球生殖遺傳學市場正經歷顯著成長，這得益於發展中國家對基因工程日益成長的認知。此外，醫療檢測報銷範圍的不斷擴大以及政府機構對開發新診斷中心的多項投資，顯著增加了全球各地對生殖遺傳學的需求。此外，先進檢測的顯著成長，以及不同年齡層女性對安全生活意識的不斷提高，預計將進一步增加對生殖遺傳學的需求，從而推動市場成長。

關鍵市場促進因素

遺傳性疾病和不孕症發病率不斷上升

主要市場挑戰

基因檢測的倫理和法律問題

主要市場趨勢

非侵入性產前檢測（NIPT）需求不斷成長

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球生殖遺傳學市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按組件（實驗室開發的測試、試劑盒和測定、試劑和耗材）
  • 依技術（次世代定序、聚合酶鍊式反應、原位雜合技術、微陣列）
  • 依程序類型（帶因者篩檢、產前篩檢、植入前基因檢測、不孕症基因檢測）
  • 按應用（非整倍體、單基因疾病、染色體結構異常、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 按組件
  • 依技術
  • 依手術類型
  • 按應用
  • 按地區

第6章：北美生殖遺傳學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲生殖遺傳學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太生殖遺傳學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲生殖遺傳學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲生殖遺傳學市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 併購
• 產品發布

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品/服務的威脅

第 14 章：全球生殖遺傳學市場：SWOT 分析

第 15 章：競爭格局

• CooperSurgical, Inc.
• Centogene AG
• Invitae Corporation
• Illumina, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Natera, Inc
• Eurofins Scientific SE

第 16 章：策略建議

第17章調查會社について,免責事項

Global Reproductive Genetics Market was valued at USD 5.87 billion in 2024 and is expected to reach USD 12.56 billion by 2030 with a CAGR of 13.52% during the forecast period. The global market for Reproductive Genetics is experiencing significant growth, driven by the growing awareness towards genetic engineering in the developing countries, to get better. Additionally, growing reimbursement improvements for medical tests and initiative, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing along with increasing awareness among different age group women for leading safe life, are further expected to increase the demand for reproductive genetics, thereby fuelling the market growth.

Key Market Drivers

Increasing Incidence of Genetic Disorders and Infertility

One of the primary growth drivers for the reproductive genetics market is the rising incidence of genetic disorders and infertility worldwide. According to the World Health Organization (WHO), approximately 10% to 15% of couples globally experience infertility, and the number is rising due to changing lifestyles, environmental factors, and delayed family planning. At the same time, the prevalence of heritable genetic conditions such as Down syndrome, cystic fibrosis, and thalassemia has heightened the demand for early detection and diagnosis through genetic testing.

Reproductive genetic testing methods, such as preimplantation genetic testing (PGT), carrier screening, and non-invasive prenatal testing (NIPT), help assess genetic risks in embryos and fetuses, allowing couples to make informed reproductive decisions. For instance, the Centers for Disease Control and Prevention (CDC) has reported that the number of assisted reproductive technology (ART) cycles performed in the United States has grown steadily, reaching nearly 330,000 cycles in 2021. Many of these ART cycles now integrate reproductive genetic tests to ensure healthy pregnancies.

Governments across Europe and Asia are also promoting national screening programs for conditions such as thalassemia and Tay-Sachs disease, particularly in high-prevalence regions. Such public health initiatives have further solidified the role of genetic diagnostics in reproductive health. Consequently, as the burden of infertility and inherited disorders continues to rise, reproductive genetic testing is becoming a critical part of reproductive healthcare globally.

Key Market Challenges

Ethical and Legal Concerns Surrounding Genetic Testing

One of the most pressing challenges facing the reproductive genetics market is the complex web of ethical and legal issues. Genetic testing, especially in the context of reproduction, raises serious concerns related to privacy, consent, genetic discrimination, and the potential for "designer babies." The ethical dilemma is particularly pronounced in prenatal and preimplantation genetic testing, where the ability to select embryos based on genetic characteristics has sparked debates about eugenics and social equity. Laws vary widely across countries. For example, Germany strictly regulates embryo selection, while the United States offers broader flexibility, often guided by private clinics' policies.

There is also concern about data protection. Genetic information is highly sensitive, and breaches can lead to discrimination in insurance and employment. While regulations like the Genetic Information Nondiscrimination Act (GINA) in the U.S. provide some protection, gaps still exist in areas such as long-term care insurance. Moreover, reproductive genetic testing may disproportionately benefit higher-income groups, exacerbating healthcare disparities. In countries without universal healthcare, the high cost of these tests may place them out of reach for many, even though government-supported initiatives are increasing access.

Key Market Trends

Rising Demand for Non-Invasive Prenatal Testing (NIPT)

A major trend reshaping the global reproductive genetics landscape is the increasing adoption of non-invasive prenatal testing (NIPT). This technique analyzes cell-free fetal DNA circulating in maternal blood to detect chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13 as early as the 10th week of pregnancy. NIPT has gained rapid clinical acceptance due to its safety (as it avoids amniocentesis or chorionic villus sampling), high sensitivity, and low false-positive rates. According to the American College of Obstetricians and Gynecologists (ACOG), NIPT is now recommended for all pregnant women regardless of age or risk level. This policy shift has dramatically expanded the target patient population.

Globally, many countries have integrated NIPT into public health strategies. For instance, in 2021, the Netherlands became one of the first countries to fully reimburse NIPT as part of routine prenatal screening. Similar policies are being adopted in Canada, Germany, and parts of Asia, including China and Japan. Furthermore, technological innovations such as single-molecule sequencing and machine learning-based analysis platforms are making NIPT more accurate and cost-effective. With a growing number of pregnancies being managed with NIPT, this trend is expected to substantially boost demand for reproductive genetic services over the next decade.

Key Market Players

• CooperSurgical, Inc.
• Centogene AG
• Invitae Corporation
• Illumina, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Natera, Inc
• Eurofins Scientific SE

Report Scope:

In this report, the Global Reproductive Genetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reproductive Genetics Market, By Component:

• Laboratory Developed Tests
• Kits & Assays
• Reagents & Consumables

Reproductive Genetics Market, By Technology:

• Next Generation Sequencing
• Polymerase Chain Reaction
• In Situ Hybridization
• Microarrays

Reproductive Genetics Market, By Procedure Type:

• Carrier Screening
• Prenatal Screening
• Preimplantation Genetic Testing
• Infertility Genetic Testing

Reproductive Genetics Market, By Application:

• Aneuploidy
• Single Gene Disorder
• Structural Chromosomal Abnormality
• Others

Reproductive Genetics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Reproductive Genetics Market.

Available Customizations:

Global Reproductive Genetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)
  • 5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)
  • 5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)
  • 5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Component
  • 5.3.2. By Technology
  • 5.3.3. By Procedure Type
  • 5.3.4. By Application
  • 5.3.5. By Region

6. North America Reproductive Genetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technology
  • 6.2.3. By Procedure Type
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reproductive Genetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Procedure Type
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Reproductive Genetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Procedure Type
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Reproductive Genetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Procedure Type
      • 6.3.3.2.4. By Application

7. Europe Reproductive Genetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Procedure Type
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Reproductive Genetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Procedure Type
      • 7.3.1.2.4. By Application
  • 7.3.2. Germany Reproductive Genetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Procedure Type
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Reproductive Genetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Procedure Type
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Reproductive Genetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Procedure Type
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Reproductive Genetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Procedure Type
      • 7.3.5.2.4. By Application

8. Asia-Pacific Reproductive Genetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Procedure Type
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Reproductive Genetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Procedure Type
      • 8.3.1.2.4. By Application
  • 8.3.2. India Reproductive Genetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Procedure Type
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Reproductive Genetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Procedure Type
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Reproductive Genetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Procedure Type
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Reproductive Genetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Procedure Type
      • 8.3.5.2.4. By Application

9. South America Reproductive Genetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Procedure Type
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Reproductive Genetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Procedure Type
      • 9.3.1.2.4. By Application
  • 9.3.2. Argentina Reproductive Genetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Procedure Type
      • 9.3.2.2.4. By Application
  • 9.3.3. Colombia Reproductive Genetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Procedure Type
      • 9.3.3.2.4. By Application

10. Middle East and Africa Reproductive Genetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Procedure Type
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Reproductive Genetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Procedure Type
      • 10.3.1.2.4. By Application
  • 10.3.2. Saudi Arabia Reproductive Genetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Procedure Type
      • 10.3.2.2.4. By Application
  • 10.3.3. UAE Reproductive Genetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Procedure Type
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Reproductive Genetics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. CooperSurgical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Centogene AG
• 15.3. Invitae Corporation
• 15.4. Illumina, Inc.
• 15.5. Myriad Genetics, Inc.
• 15.6. Thermo Fisher Scientific Inc.
• 15.7. Laboratory Corporation of America Holdings
• 15.8. Quest Diagnostics
• 15.9. Natera, Inc
• 15.10. Eurofins Scientific SE

16. Strategic Recommendations

17. About Us & Disclaimer